Forian (NASDAQ:FORA) Trading 0.3% Higher - What's Next?

Key Points

• Forian Inc. (NASDAQ:FORA) shares increased by 0.3% during Tuesday’s trading, closing at $1.93 after reaching a high of $1.94.
• In its latest earnings report, Forian posted a loss per share of ($0.04), missing expectations, but exceeded revenue forecasts with $7.06 million in revenue for the quarter.
• Oracle Investment Management Inc. raised its stake in Forian by 0.7%, making it about 1.5% of their portfolio, with a total ownership of 4.40% of Forian's stock.

Forian Inc. (NASDAQ:FORA - Get Free Report) rose 0.3% on Tuesday . The company traded as high as $1.94 and last traded at $1.93. Approximately 7,938 shares changed hands during mid-day trading, a decline of 59% from the average daily volume of 19,312 shares. The stock had previously closed at $1.92.

Forian Trading Down 0.8%

The firm's 50-day moving average price is $2.02 and its 200 day moving average price is $2.11. The company has a market capitalization of $59.13 million, a price-to-earnings ratio of -21.06 and a beta of 1.00.

Forian (NASDAQ:FORA - Get Free Report) last posted its quarterly earnings results on Wednesday, May 14th. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.06). The firm had revenue of $7.06 million during the quarter, compared to the consensus estimate of $5.37 million.

Institutional Trading of Forian

A hedge fund recently raised its stake in Forian stock. Oracle Investment Management Inc. grew its position in shares of Forian Inc. (NASDAQ:FORA - Free Report) by 0.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,366,107 shares of the company's stock after purchasing an additional 10,000 shares during the quarter. Forian comprises approximately 1.5% of Oracle Investment Management Inc.'s investment portfolio, making the stock its 8th largest position. Oracle Investment Management Inc. owned approximately 4.40% of Forian worth $2,814,000 at the end of the most recent reporting period. 19.25% of the stock is currently owned by institutional investors.

About Forian

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.